Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECTOR: VTE Prophylaxis in Gastrectomy
NCT01448746Phase 3Unknown
- Sponsor
- The Catholic University of Korea
- Start
- Oct 2011
- Primary completion
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in venous thromboembolism (VTE), sponsored by The Catholic University of Korea. Status: unknown.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01448746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448746.